Getting Wegovy Online in the UK: What the Process Actually Looks Like

Step 1, Find out whether Wegovy is clinically suitable for you

Before anything else, a prescriber needs enough information to make a safe decision. At nume (at a regulated online pharmacy like ours) that starts with a structured consultation covering your weight, relevant health conditions, current medicines and medical history. This is not a form that gets auto-approved. A GPhC-registered Independent Prescriber reads your answers personally.

The licensed criteria for Wegovy broadly require a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. These are the starting-point criteria, not a guarantee of approval: the prescriber weighs the complete picture, including any medicines that might interact. Our semaglutide information page covers the clinical background in more detail.

If you are already on treatment elsewhere and want to transfer, a responsible pharmacy will ask for evidence of your current dose and your clinical history, not simply take your word for it. That step exists to protect you.

Step 2, Identity and weight checks, then the prescription is issued

Reputable online Wegovy services in the UK verify who you are and confirm your weight before a prescription is issued. At nume, that means photo-ID verification and live weight confirmation on video. These are not bureaucratic hurdles; they are the clinical safeguards that make remote prescribing safe.

Once approved, the prescription is generated by the prescriber and the medicine is dispensed from the pharmacy's own MHRA-regulated stock. You can verify any online pharmacy's registration directly on the GPhC pharmacy register, it takes about thirty seconds and is the single most useful check you can make.

The MHRA has warned publicly about counterfeit weight-loss pens circulating online and through social media. Some fake pens have contained insulin rather than semaglutide. The red flags are consistent: medicines offered without a clinical assessment, prices far below anything a licensed supply chain could support, and sellers operating outside the GPhC register. If you come across any of these, the right move is to report the seller through the MHRA Yellow Card scheme rather than buy.

Step 3, Delivery, storage and getting started

Once dispensed, Wegovy pens are sent in temperature-controlled packaging. The pens require refrigeration at 2–8°C, many people keep theirs in the fridge door, which works fine as long as they are not stored near a freezer compartment. The Patient Information Leaflet details the exact room-temperature window; always check it before travelling.

Treatment begins at a low dose to allow your system to adjust, with the prescriber increasing the dose on a planned schedule over several months. The Wegovy SmPC sets out the full licensed schedule; your prescriber follows this alongside your individual response. In the STEP 1 clinical trial (published in the New England Journal of Medicine) participants taking semaglutide 2.4mg achieved an average body-weight reduction of around 15% over 68 weeks alongside lifestyle changes. The newer 7.2mg dose, approved by the MHRA in April 2026, showed around 20.7% average weight loss in trials, narrowing the gap with the results seen in tirzepatide studies.

If you have questions about cost before starting, our Wegovy cost guide explains what private treatment typically involves and why price alone is the wrong filter for a prescription medicine.

What separates a safe online Wegovy service from an unsafe one

The NHS's own guidance on weight-management injections sets out what responsible prescribing looks like, and the principles apply equally to private online services. A legitimate online Wegovy service will always confirm your identity, verify your weight, have a qualified prescriber review your consultation, notify your GP in line with professional guidance, and offer clinical support if side effects arise. None of those steps should be optional. NHS England's guidance on weight-management injections is worth reading if you want to understand the clinical framework these services operate within.

Common side effects of semaglutide are primarily gastrointestinal: nausea, loose stools, constipation and indigestion are the most frequently reported, especially in the early weeks of each dose increase. They tend to settle. Less commonly, pancreatitis has been associated with GLP-1 medicines; the MHRA issued a Drug Safety Update on this in January 2026. Severe stomach pain that extends to the back is the symptom to take seriously and get checked promptly. Your prescriber and the Patient Information Leaflet are the right sources for a full side-effect discussion, not a general webpage.

Under-18s, anyone who is pregnant, breastfeeding or actively trying to conceive should not use Wegovy. Women of childbearing age should discuss contraception with their prescriber before starting, as there are specific guidance points around oral contraceptives and GLP-1 medicines. Practical guidance on getting Wegovy online covers these and other frequently asked pre-treatment questions.

When you are ready to find out whether you are eligible, checking your eligibility with our clinical team is the place to start, and if you have already confirmed your suitability, you can buy Wegovy online through our GPhC-registered pharmacy directly.